Bente Vilsen Selected Research

Dystonia 12

1/2021	ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.
4/2015	Rescue of Na+ affinity in aspartate 928 mutants of Na+,K+-ATPase by secondary mutation of glutamate 314.
5/2014	Distinct neurological disorders with ATP1A3 mutations.
2/2014	Relationship between intracellular Na+ concentration and reduced Na+ affinity in Na+,K+-ATPase mutants causing neurological disease.
8/2010	The rapid-onset dystonia parkinsonism mutation D923N of the Na+, K+-ATPase alpha3 isoform disrupts Na+ interaction at the third Na+ site.
7/2009	A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism.
1/2009	The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations.
5/2008	[The Na+,K+ pump continues to cause surprise].
7/2006	Mutations Phe785Leu and Thr618Met in Na+,K+-ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bente Vilsen Research Topics

Disease

9	Dystonia 12 01/2021 - 07/2006
5	Nervous System Diseases (Neurological Disorders) 12/2019 - 05/2008
4	Migraine with Aura (Familial Hemiplegic Migraine) 01/2021 - 05/2008
4	Alternating hemiplegia of childhood 01/2021 - 02/2014
3	Cerebellar Ataxia (Dysmetria) 01/2021 - 04/2014
3	Intellectual Disability (Idiocy) 12/2019 - 04/2014
2	Seizures (Absence Seizure) 11/2018 - 08/2009
2	familial type 2 Hemiplegic migraine 02/2014 - 01/2009
2	Adenoma (Adenomas) 01/2014 - 04/2013
2	Benign Familial Pemphigus (Hailey Hailey Disease) 02/2006 - 11/2005
1	Optic Atrophy 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	CAPOS syndrome 01/2019
1	Dysequilibrium syndrome 04/2014
1	Hyperaldosteronism (Conn Syndrome) 01/2014
1	Hypertension (High Blood Pressure) 04/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2011
1	Mania (Manias) 11/2011
1	Epilepsy (Aura) 08/2009
1	Decompression Sickness (Bends) 08/2005
1	Darier Disease (Darier's Disease) 11/2003

Drug/Important Bio-Agent (IBA)

18	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 11/2003
8	Protein Isoforms (Isoforms)IBA 01/2021 - 11/2003
3	Proteins (Proteins, Gene)FDA Link 11/2017 - 11/2011
2	AldosteroneIBA 01/2014 - 04/2013
1	P-type ATPasesIBA 12/2019
1	Ion Pumps (Ion Pump)IBA 12/2019
1	EnzymesIBA 01/2019
1	MagnesiumIBA 11/2018
1	Glutamic Acid (Glutamate)FDA Link 11/2017
1	Aspartic Acid (Aspartate)FDA Link 04/2015
1	AsparagineIBA 04/2015
1	Isoleucine (L-Isoleucine)FDA Link 04/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2014
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2014
1	rostafuroxinIBA 11/2011
1	LithiumIBA 11/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2011
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 11/2011
1	sulconazole (Myk)FDA Link 08/2009
1	SodiumIBA 07/2009

Therapy/Procedure

1	Therapeutics 11/2011